Maximize Your Impact at Advanced Therapies Week 2026
Advanced Therapies Week 2026, taking place on February 9 at the San Diego Convention Center, brings together key decision-makers from the cell and gene therapy sector. This event plays a pivotal role in shaping commercial, clinical, and regulatory strategies for organizations across biotech, pharma, and health systems. Attendees include C-level executives, VPs of R&D, heads of manufacturing, commercialization leaders, and senior figures from investment and regulatory agencies.
The conference serves as a high-value environment where technology evaluations, funding discussions, and long-term partnerships are often initiated or finalized. It’s an opportunity to engage executives with budget authority who are exploring new tools, platforms, and collaborations that can accelerate their therapeutic pipelines. By using Vendelux’s enriched attendee list, commercial teams gain critical context on who will be there, what roles they play in the decision-making cycle, and how to approach them before the event for maximum impact.
How Sales, Marketing and Revops Teams Can Use This Attendee List
Advanced Therapies Week attracts professionals leading innovation in cell and gene therapy, many of whom influence product development, strategic partnerships, and purchasing decisions. Commercial teams can use the enriched attendee list to identify and prioritize stakeholders in regulatory affairs, clinical operations, and manufacturing strategy.
Segmenting contacts by company type—whether early-stage biotech, CDMO, Big Pharma, or health systems—helps teams tailor messaging and outreach flows. Marketing teams can structure early campaigns around pain points such as scalability, time-to-market, or CMC compliance, while sales teams can secure pre-event meetings with decision-makers already evaluating solutions in these areas.
The attendee data enables operational teams to prepare for quick and relevant follow-ups based on session attendance or booth visits. With verified contacts and LinkedIn profiles, your outreach becomes more targeted and actionable—leading to more meetings, stronger value conversations, and longer-term relationships seeded on-site.
Timing Is Everything
Advanced Therapies Week 2026 is scheduled for February 9, 2026. With many attendees already setting meeting schedules months in advance, early outreach allows you to capture time with senior stakeholders before calendars fill up.
Using Vendelux, your team can access enriched attendee data well ahead of the event to align campaigns, prioritize outreach, and optimize your presence on-site. February events mark the start of many teams’ planning cycles, making this a critical time to establish new vendor relationships and influence budgets for the year.
What’s Included in the Advanced Therapies Week 2026 Attendee List?
Vendelux provides visibility into executives expected to attend Advanced Therapies Week 2026 through a mix of organizer data and predictive insights. Clients can upload a list of key target accounts and receive matched attendee profiles to focus on high-value opportunities.
The enriched list includes first and last name, job title, company name, company website, city, state, country, LinkedIn profile, verified email address, and phone numbers when available.
Where Is Advanced Therapies Week 2026?
The event will be held at the San Diego Convention Center in San Diego, California, United States.
When Is Advanced Therapies Week 2026?
Advanced Therapies Week 2026 takes place on February 9, 2026.
What Type of Event Is Advanced Therapies Week 2026?
Advanced Therapies Week is a leading conference for the cell and gene therapy sector, combining scientific programming with commercial and regulatory insights. The agenda includes keynotes from biotech CEOs, interactive panels with industry regulators, innovation showcases, and networking opportunities tailored for executive-level professionals.
How Many People Attend Advanced Therapies Week 2026?
Advanced Therapies Week is expected to host over 2,500 attendees from more than 40 countries. The audience includes senior leaders from biotech companies, pharmaceutical firms, regulatory agencies, academic institutions, and capital groups. The majority of attendees hold director-level roles and above, with significant influence over purchasing and strategic decisions.
